Skip to main content
    C

    Carlsmed, Inc. (CARL)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $17.35
    +0.23 (+1.34%)

    Market Cap: $469.16M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    71%(5/7)
    Avg Surprise
    +4.62%
    Streak
    5 Q

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.39
    Range-$0.40 - -$0.35
    7 analysts
    Revenue Consensus
    $23.22M
    Range$21.98M - $24.46M
    7 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.35
    Range-$0.35 - -$0.35
    1 analysts
    EPS Revisions
    1
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.31-14.8%
    60d ago-$0.31-14.8%
    30d ago-$0.31-14.8%
    7d ago-$0.31-14.8%
    Current-$0.35
    Revenue Consensus
    $24.56M
    Range$24.21M - $24.80M
    3 analysts
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Mar 27EST
    Exp. May 3
    --$0.35-$0.35 - -$0.35--1
    1
    1
    30d
    -
    Dec 26EST
    Exp. Feb 24
    --$0.39-$0.40 - -$0.35--7--
    Sep 26
    Reported Nov 10
    -$0.34-$0.42N/A+19.05%Beat2
    1
    0
    30d
    +8.1%
    Jun 26
    Reported Jul 21
    -$0.39-$0.40-$0.47 - -$0.32+2.50%Beat2
    1
    1
    30d
    +71.5%
    Mar 26
    Reported May 5
    -$0.26-$0.39-$0.46 - -$0.32+33.33%Beat2
    1
    1
    30d
    +0.0%
    Dec 25
    Reported Feb 25
    -$0.32-$0.35-$0.53 - -$0.29+7.51%Beat3
    0
    2
    30d
    -
    Sep 25
    Reported Nov 6
    -$0.37-$0.49N/A+24.49%Beat---
    Jun 25
    Reported Aug 28
    -$1.37-$0.91N/A-50.55%Miss---
    Mar 25
    Reported Jun 26
    -$0.26-$0.25N/A-4.00%Miss---

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-13.10xFCF Yield-7.63%
    Profitability
    Profit Margin-55.80%Operating Margin-59.00%
    ROE-44.00%ROIC-36.71%
    Financial Health
    Debt/Equity0.20xInterest Coverage-33.33x
    Current Ratio5.79xQuick Ratio5.62x
    Trading Statistics
    BetaN/AAvg Volume144.60K
    52-Week High$19.1552-Week Low$8.50

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 15.7% above its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 58.5, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$16.15
    SMA 20$15.52
    SMA 50$15.00
    SMA 200$12.57
    EMA 10$16.43
    EMA 20$15.81
    EMA 50$15.09
    EMA 200$13.54

    MACD

    Line: 0.66Signal: 0.40Hist: 0.26

    ADX

    ADX: 23.0+DI: 31.5-DI: 10.5

    Aroon & PSAR

    Aroon Up88.0
    Aroon Down20.0
    PSAR$14.31

    Bollinger Bands

    Upper Band$17.96
    Lower Band$13.08
    %B Position3142%(Upper)
    Band Width0.87

    RSI (14-Day)

    Neutral
    58.5

    Momentum Oscillators

    Stoch %K63.1
    Stoch %D65.2
    Williams %R-35.1
    ROC (10d)15.5%
    Momentum2.33
    CCI (20d)168.6
    MFI (14d)63.2

    Volatility Measures

    ATR (14d)$1.34(7.7%)
    StdDev (20d)1.22
    Hist Vol124.5%(High)

    Volume Flow

    VWAP$17.68
    OBV972.4K
    AD Line-1.8M
    CMF (20d)-0.082

    Volume Metrics

    Avg Vol (20d)149.0K
    Vol Ratio1.3x
    VWMA (20d)$16.37

    Pivot Points

    R3$18.78
    R2$18.24
    R1$17.68
    Pivot Point$17.14
    S1$16.58
    S2$16.04
    S3$15.48

    Advanced Oscillators

    TSI14.21
    Ultimate Osc51.1
    KST107.26

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$21.55M$18.94M$16.12M$15.16M$13.07M$12.08M$10.19M$9.41M$6.59M$6.08M$5.09M4.34M
    Cost of Revenue$4.89M$4.40M$3.69M$3.56M$3.15M$3.21M$2.55M$2.38M$1.79M$1.52M$1.42M1.22M
    Gross Profit$16.66M$14.54M$12.43M$11.61M$9.93M$8.87M$7.64M$7.02M$4.80M$4.56M$3.66M3.12M
    Operating Expenses$29.37M$25.58M$21.70M$26.64M$18.96M$15.37M$13.36M$50.57M$12.57M$10.88M$8.99M8.55M
    R&D$6.38M$6.04M$5.18M$5.26M$4.45M$4.16M$3.15M$3.02M$4.04M$4.00M$3.26M0
    SG&A$9.98M$7.62M$6.23M$4.85M$4.91M$3.34M$3.47M$2.33M$1.92M$2.01M$2.14M0
    Operating Income-$12.70M-$11.04M-$9.28M-$15.04M-$9.04M-$6.50M-$5.72M-$43.55M-$7.78M-$6.32M-$5.33M-5.43M
    Interest Income$772.00K$839.00K$891.00K$1.03M$954.00K$336.00K$380.00K$410.00K$394.00K$428.00K$98.00K0
    Interest Expense$316.00K$313.00K$311.00K$687.00K$380.00K$363.00K$357.00K$378.00K$402.00K$325.00K$216.00K107.00K
    Income Before Tax-$12.24M-$10.51M-$8.70M-$14.93M-$8.53M-$6.77M-$5.73M-$4.72M-$7.81M-$6.28M-$5.45M-5.54M
    Income Tax ExpenseN/A$0$0$0$0$0$0$0$0$0$00
    Net Income-$12.24M-$10.51M-$8.70M-$9.20M-$8.53M-$6.77M-$5.73M-$4.72M-$7.81M-$6.28M-$5.45M-5.54M
    EBITDA-$12.68M-$10.91M-$9.18M-$14.14M-$9.02M-$6.68M-$5.71M-$4.30M-$7.77M-$6.38M-$5.29M-5.54M
    EBIT-$12.70M-$11.04M-$9.28M-$14.24M-$9.10M-$6.74M-$5.75M-$4.34M-$7.80M-$6.38M-$5.33MN/A
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about CARL

    News

    CARL Valuation

    GNG's valuation label for CARL is Overvalued.

    P/FCF
    -13.1x
    P/B
    6.3x
    All CARL metrics

    CARL Profitability: Margins, ROIC and FCF

    Carlsmed (CARL) has a gross margin of 77.0%, an operating margin of -59.0% and a net margin of -55.8%. It posts -36.7% ROIC and a -50.4% FCF margin.

    Gross margin
    77.0%
    Operating margin
    -59.0%
    Net margin
    -55.8%
    ROIC
    -36.7%
    ROE
    -44.0%
    FCF margin
    -50.4%
    FCF yield
    -7.6%

    The companies most similar to Carlsmed (CARL) include Sophia Genetics SA, NRC Health and Simulations Plus.

    Sector: Healthcare

    Companies most similar to Carlsmed

    CARL Analyst Ratings

    Carlsmed (CARL) has a Buy consensus from 5 analysts: 5 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    2
    Buy
    3
    Hold
    0
    Sell
    0
    Strong Sell
    0
    CARL stock forecast

    CARL Bull Case vs Bear Case

    Bull case

    • CARL grew quarterly revenue 64.9% year over year.
    • 100.0% of CARL's analyst ratings are Buy or Strong Buy.

    Bear case

    • CARL has a -55.8% net profit margin.

    CARL Earnings: Beat Rate and Next Report

    Carlsmed (CARL) beat the EPS estimate in 5 of the last 7 quarters (71.4%). Its next report is expected on Feb 24, 2027.

    Beat rate
    5 of 7 quarters (71.4%)
    Average surprise
    4.6%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.39

    CARL Earnings Date

    CARL reports Feb 24, 2027. The date is estimated.

    CARL Earnings Call

    The latest CARL earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Updated Nov 10, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About CARL

    When does CARL report earnings?

    Carlsmed, Inc. (CARL) is expected to report earnings on Feb 24, 2027.

    Does CARL pay dividends?

    Carlsmed, Inc. (CARL) does not currently pay a regular dividend.

    What is CARL's market cap?

    Carlsmed, Inc. (CARL) has a market capitalization of $469.16M with a current stock price of $17.35.

    Did CARL beat earnings estimates last quarter?

    Yes. Carlsmed, Inc. (CARL) reported EPS of -$0.34 for the quarter ended Sep 30, 2026, above the -$0.42 estimate, a 19.0% surprise.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.